FI943421A0 - 1,5-bensodiazepinderivat och deras användning som medicin - Google Patents

1,5-bensodiazepinderivat och deras användning som medicin

Info

Publication number
FI943421A0
FI943421A0 FI943421A FI943421A FI943421A0 FI 943421 A0 FI943421 A0 FI 943421A0 FI 943421 A FI943421 A FI 943421A FI 943421 A FI943421 A FI 943421A FI 943421 A0 FI943421 A0 FI 943421A0
Authority
FI
Finland
Prior art keywords
medicine
benzodiazepine derivatives
benzodiazepine
derivatives
Prior art date
Application number
FI943421A
Other languages
English (en)
Finnish (fi)
Other versions
FI943421A (sv
FI111632B (sv
Inventor
Harry Finch
David Gordon Trist
Giorgio Tarzia
Aldo Feriani
Original Assignee
Glaxo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Spa filed Critical Glaxo Spa
Publication of FI943421A0 publication Critical patent/FI943421A0/sv
Publication of FI943421A publication Critical patent/FI943421A/sv
Application granted granted Critical
Publication of FI111632B publication Critical patent/FI111632B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/121,5-Benzodiazepines; Hydrogenated 1,5-benzodiazepines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI943421A 1992-01-21 1994-07-19 Förfarande för framställning av CCK-B-antagonistiskt verkande 1,5-bensodiazepinderivat FI111632B (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB929201180A GB9201180D0 (en) 1992-01-21 1992-01-21 Chemical compounds
GB9201180 1992-01-21
PCT/EP1993/000098 WO1993014074A1 (en) 1992-01-21 1993-01-19 1,5-benzodiazepine derivatives and their use in medicine
EP9300098 1993-01-19

Publications (3)

Publication Number Publication Date
FI943421A0 true FI943421A0 (sv) 1994-07-19
FI943421A FI943421A (sv) 1994-07-19
FI111632B FI111632B (sv) 2003-08-29

Family

ID=10708914

Family Applications (1)

Application Number Title Priority Date Filing Date
FI943421A FI111632B (sv) 1992-01-21 1994-07-19 Förfarande för framställning av CCK-B-antagonistiskt verkande 1,5-bensodiazepinderivat

Country Status (29)

Country Link
US (2) US5580895A (sv)
JP (1) JP3253723B2 (sv)
KR (1) KR100263625B1 (sv)
CN (1) CN1049217C (sv)
AP (1) AP369A (sv)
AU (2) AU3450193A (sv)
BG (1) BG61876B1 (sv)
CA (1) CA2087672C (sv)
CZ (1) CZ283950B6 (sv)
FI (1) FI111632B (sv)
GB (1) GB9201180D0 (sv)
GE (1) GEP20001968B (sv)
HU (2) HU221297B1 (sv)
IL (1) IL104447A (sv)
IS (1) IS3970A (sv)
MX (1) MX9300261A (sv)
MY (1) MY131307A (sv)
NO (1) NO305952B1 (sv)
NZ (1) NZ245715A (sv)
OA (1) OA09964A (sv)
PH (1) PH30894A (sv)
PL (1) PL175340B1 (sv)
RO (1) RO114128B1 (sv)
RU (1) RU2124009C1 (sv)
SK (1) SK280173B6 (sv)
TW (1) TW226013B (sv)
UA (1) UA29416C2 (sv)
WO (1) WO1993014074A1 (sv)
ZA (1) ZA93375B (sv)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9225492D0 (en) * 1992-12-05 1993-01-27 Glaxo Group Ltd Amine derivatives
GB9307833D0 (en) * 1993-04-15 1993-06-02 Glaxo Inc Modulators of cholecystokinin and gastrin
PL311083A1 (en) * 1993-04-15 1996-02-05 Glaxo Wellcome Inc Derivatives of 1,5-bezodiazepine exhibiting antagonistic activity of cck and/or gastrin
GB9308421D0 (en) * 1993-04-23 1993-06-09 Glaxo Spa Chemical compounds
GB9308431D0 (en) * 1993-04-23 1993-06-09 Glaxo Spa Chemical compounds
GB9314977D0 (en) * 1993-07-20 1993-09-01 Glaxo Spa Chemical compounds
GB2280182A (en) * 1993-07-20 1995-01-25 Glaxo Spa Benzodiazepine derivatives
GB9314981D0 (en) * 1993-07-20 1993-09-01 Glaxo Spa Chemical compounds
GB9315018D0 (en) * 1993-07-20 1993-09-01 Glaxo Spa Chemical compounds
US5739129A (en) * 1994-04-14 1998-04-14 Glaxo Wellcome Inc. CCK or gastrin modulating 5-heterocyclic-1, 5 benzodiazepines
RU2152939C1 (ru) * 1994-04-14 2000-07-20 Глаксо Веллкам Инк. 5-гетероцикло-1,5-бензодиазепины и их фармацевтически приемлемые соли
PE27497A1 (es) * 1994-04-15 1997-08-07 Glaxo Inc Derivados de 1,5 benzodiazepina
GB9420748D0 (en) * 1994-10-14 1994-11-30 Glaxo Inc 1,5 benzodiazepine derivatives
US5780464A (en) * 1994-10-14 1998-07-14 Glaxo Wellcome Inc. Enteric coated compositions of 1,5-benzodiazepine derivatives having CCK antagonistic or agonistic activity
US5750353A (en) * 1995-12-11 1998-05-12 New England Medical Center Hospitals, Inc. Assay for non-peptide agonists to peptide hormone receptors
JP4442930B2 (ja) 1995-12-11 2010-03-31 タフツ メディカル センター インコーポレイテッド ペプチドホルモンレセプターリガンドに関するアッセイ法およびその使用
PT945445E (pt) * 1996-12-10 2004-01-30 Zeria Pharm Co Ltd Derivados de 1,5-benzodiazepina
KR20050100615A (ko) 2003-01-14 2005-10-19 싸이토키네틱스, 인코포레이티드 화합물, 조성물 및 방법
GB0307918D0 (en) * 2003-04-05 2003-05-14 Astrazeneca Ab Therapeutic use
KR20060125805A (ko) * 2003-11-18 2006-12-06 베링거 인겔하임 인터내셔날 게엠베하 고체 약제학적 제제 형태
MXPA06014495A (es) 2004-06-17 2007-03-01 Cytokinetics Inc Compuestos, composiciones y metodos.
US7538223B2 (en) 2005-08-04 2009-05-26 Cytokinetics, Inc. Compounds, compositions and methods
US7825120B2 (en) 2005-12-15 2010-11-02 Cytokinetics, Inc. Certain substituted ((piperazin-1-ylmethyl)benzyl)ureas
US20070161617A1 (en) 2005-12-15 2007-07-12 Morgan Bradley P Certain chemical entities, compositions and methods
WO2007078815A2 (en) 2005-12-16 2007-07-12 Cytokinetics, Inc. Certain chemical entities, compositions, and methods
WO2007078839A2 (en) 2005-12-19 2007-07-12 Cytokinetics, Inc. Compounds, compositions and methods
CU20090172A6 (es) 2009-10-09 2011-10-05 Facultad De Quimica Universidad De La Habana Sistemas tricíclicos y tetracíclicos con actividad sobre el sistema nervioso central y vascular
US9725490B2 (en) 2011-07-29 2017-08-08 Tokushima University ERAP1-derived peptide and use thereof
CN103435562B (zh) * 2013-08-26 2016-02-24 华东理工大学 6-取代苯并二氮卓-2,4-二酮类化合物及其用途
AU2016297024B2 (en) 2015-07-22 2021-03-04 Enanta Pharmaceuticals, Inc. Benzodiazepine derivatives as RSV inhibitors
EP3402799B1 (en) 2016-01-15 2022-05-04 Enanta Pharmaceuticals, Inc. Heterocyclic compounds as rsv inhibitors
EP3582784B1 (en) 2017-02-16 2022-06-08 Enanta Pharmaceuticals, Inc. Processes for the preparation of benzodiazepine derivatives
WO2018226801A1 (en) * 2017-06-07 2018-12-13 Enanta Pharmaceuticals, Inc. Aryldiazepine derivatives as rsv inhibitors
WO2019006291A1 (en) 2017-06-30 2019-01-03 Enanta Pharmaceuticals, Inc. HETEROCYCLIC COMPOUNDS AS RSV INHIBITORS
WO2019006295A1 (en) 2017-06-30 2019-01-03 Enanta Pharmaceuticals, Inc. HETEROCYCLIC COMPOUNDS AS RSV INHIBITORS
WO2019067864A1 (en) 2017-09-29 2019-04-04 Enanta Pharmaceuticals, Inc. PHARMACEUTICAL AGENTS IN COMBINATION AS INHIBITORS OF RSV
WO2019094920A1 (en) 2017-11-13 2019-05-16 Enanta Pharmaceuticals, Inc. Azepin-2-one derivatives as rsv inhibitors
WO2019199908A1 (en) 2018-04-11 2019-10-17 Enanta Pharmaceuticals, Inc. Heterocyclic compounds as rsv inhibitors
WO2020111167A1 (ja) 2018-11-30 2020-06-04 国立大学法人徳島大学 Big3-phb2相互作用阻害phb2由来ペプチドを含む乳がん治療薬
MX2021011144A (es) 2019-03-18 2022-01-18 Enanta Pharm Inc Derivados de las benzodiazepinas como inhibidores del vsr.
WO2020210246A1 (en) 2019-04-09 2020-10-15 Enanta Pharmaceuticals, Inc, Heterocyclic compounds as rsv inhibitors
US11505558B1 (en) 2019-10-04 2022-11-22 Enanta Pharmaceuticals, Inc. Antiviral heterocyclic compounds
UY39032A (es) 2020-01-24 2021-07-30 Enanta Pharm Inc Compuestos heterocíclicos como agentes antivirales
US11534439B2 (en) 2020-07-07 2022-12-27 Enanta Pharmaceuticals, Inc. Dihydroquinoxaline and dihydropyridopyrazine derivatives as RSV inhibitors
US11945824B2 (en) 2020-10-19 2024-04-02 Enanta Pharmaceuticals, Inc. Heterocyclic compounds as anti-viral agents

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2641280B1 (fr) * 1988-12-29 1994-01-21 Roussel Uclaf Nouveaux derives de la 2,4-dioxo 2,3,4,5-tetrahydro 1h-1,5-benzodiazepine, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
WO1993014074A1 (en) 1993-07-22
SK280173B6 (sk) 1999-09-10
CA2087672C (en) 2003-08-05
HU221297B1 (en) 2002-09-28
IL104447A (en) 1998-02-22
IS3970A (is) 1993-07-22
NO942720L (no) 1994-07-20
RU94037768A (ru) 1996-08-10
MX9300261A (es) 1994-03-31
NO942720D0 (no) 1994-07-20
RU2124009C1 (ru) 1998-12-27
PL175340B1 (pl) 1998-12-31
AU3193593A (en) 1993-07-22
HUT67375A (en) 1995-03-28
AU661749B2 (en) 1995-08-03
AU3450193A (en) 1993-08-03
CZ173694A3 (en) 1995-09-13
FI943421A (sv) 1994-07-19
BG98881A (bg) 1995-03-31
AP369A (en) 1994-11-06
OA09964A (en) 1995-12-11
HU9402150D0 (en) 1994-09-28
US5580895A (en) 1996-12-03
RO114128B1 (ro) 1999-01-29
NO305952B1 (no) 1999-08-23
CN1049217C (zh) 2000-02-09
NZ245715A (en) 1995-07-26
KR100263625B1 (ko) 2000-11-01
ZA93375B (en) 1994-07-18
GB9201180D0 (en) 1992-03-11
UA29416C2 (uk) 2000-11-15
CN1074678A (zh) 1993-07-28
FI111632B (sv) 2003-08-29
JPH07118244A (ja) 1995-05-09
HU211295A9 (en) 1995-11-28
GEP20001968B (en) 2000-03-05
SK86494A3 (en) 1995-03-08
CZ283950B6 (cs) 1998-07-15
CA2087672A1 (en) 1993-07-22
US5637697A (en) 1997-06-10
MY131307A (en) 2007-08-30
PH30894A (en) 1997-12-23
BG61876B1 (bg) 1998-08-31
AP9300478A0 (en) 1993-01-31
JP3253723B2 (ja) 2002-02-04
IL104447A0 (en) 1993-05-13
TW226013B (sv) 1994-07-01

Similar Documents

Publication Publication Date Title
FI943421A (sv) 1,5-bensodiazepinderivat och deras användning som medicin
FI953479A (sv) 1-arylpyrimidinderivat och farmaceutisk användning av dessa
FI943570A0 (sv) 1-bensensulfonyl-1,3-dihydroindol-2-onderivat, framställning av dessa och läkemedel som innehåller dessa
DE69224656D1 (de) Arzneimittel
FI932655A (fi) Imidatderivat av farmaceutiskt anvaendbara antikonvulsiva sulfamat
FI942993A (sv) Organo-aluminoxyprodukt och användning av densamma
AU8650291A (en) Iridoid derivatives and their use as medicines
FI954491A (sv) Heterocykler innehållande imidinderivat, deras framställning och användning
FI930574A (fi) Med keramiskt pigment oeverdragna oxidbaserade haorda partiklar, foerfarande foer framstaellning och anvaendning av dessa
FI941287A (sv) Triazolokinoxalin-1,4-dioner och framställning och användning av dem
FI101382B1 (sv) Dihydroxipropylsulfoetylcellulosor, framställning och användning av dem
DE4294862T1 (de) Pharmazeutische Komposition
EE03690B1 (et) Imidasopüridasiinid, neid sisaldav ravim ja nendekasutamine
FI961977A0 (sv) N-substituerade azabicykloalkanderivat, deras framställning och användning
FI955679A (sv) Piperidinderivater, framställning och användning därav
FI933376A0 (fi) 4-amino-3-acylkinolinderivater och deras anvaendning som inhibitorer avmagsyrasekretion
NO308251B1 (no) Karbohydratderivater, farmasøytisk blanding inneholdende karbohydratderivater samt anvendelse av samme
FI933605A0 (fi) Sammansaettningar av 1-klor-2,2,2-trifluoretyldifluormetyleter och partiellt fluorerade alkanoler
FI955335A0 (fi) Bicyklopolyazamakrocyklofosfonsyror, komplex och konjugat daerav foer anvaendning som kontrastmedel och foerfarande foer framstaellning av dessa
FI942468A0 (sv) Kemiska föreningar, deras framställning och användning
BR9106372A (pt) Derivados 1,5-benzotiazepinona,suas preparacoes e uso farmaceutico
NO942228D0 (no) Ipsapiron-legemiddeltilberedning
MX9205375A (es) Nuevos derivados de bencilamina y el medicamento que los contienen.
GB9206062D0 (en) Heterocyclic compounds,their preparation and pharmaceutical use
FI934317A0 (fi) Farmaceutiska sammansaettningar, vilka innehaoller ej-joniska ytaktiva aemnen